Is ranibizumab cost-effective for proliferative diabetic retinopathy?
- Posted on: Nov 12 2019
- Leave a response
This secondary analysis of the Protocol S trial compared the cost-effectiveness of ranibizumab versus laser for proliferative diabetic retinopathy.
Source: AAO
Posted in: Uncategorized